High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea

被引:196
|
作者
Ko, Kwan Soo
Suh, Ji Yoeun
Kwon, Ki Tae
Jung, Sook-In
Park, Kyong-Hwa
Kang, Cheol In
Chung, Doo Ryeon
Peck, Kyong Ran
Song, Jae-Hoon
机构
[1] Sungkyunkwan Univ, Samsung Med Ctr, Div Infect Dis, Seoul 135710, South Korea
[2] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon, South Korea
[3] Asian Pacific Res Fdn Infect Dis ARFID, Seoul 135710, South Korea
[4] Daegu Fatima Hosp, Div Infect Dis, Taegu, South Korea
[5] Chonnam Natl Univ, Sch Med, Kwangju, South Korea
关键词
rpoB; antimicrobial resistance; subgrouping;
D O I
10.1093/jac/dkm305
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To investigate antimicrobial resistance in clinical isolates of Acinetobacter spp. from two Korean hospitals. Methods: Two hundred and sixty-five isolates of Acinetobacter spp. from two Korean hospitals were collected and were identified to species level using partial rpoB gene sequences. Antimicrobial susceptibility testing was performed using a broth microdilution method. Results: rpoB gene sequences indicated that 214 isolates (80.8%) were Acinetobacter baumannii, and allowed these to be classified into three subgroups (I, II and III); 142 isolates (53.6%) belonged to subgroup I, 54 (20.4%) to subgroup II and 18 (6.8%) to subgroup III. Forty-eight isolates (18.1%) and 74 isolates (27.9%) were resistant to polymyxin B and colistin, respectively. However, antimicrobial resistance rates varied markedly between subgroups. While A. baumannii subgroup I showed low resistance rates to polymyxin B and colistin (2.1% and 7.0%, respectively), subgroups II and III showed high resistance rates to these antibiotics (38.9% and 64.8% in subgroup II and 72.2% and 88.9%, in subgroup III, respectively). Multidrug resistance was also significantly more frequent in subgroup I (45.1%) than in subgroups II and III (13.0% and 16.7%, respectively). Conclusions: Our data indicate that subgroup identification of A. baumannii may aid selection of appropriate antimicrobial agents for the treatment of Acinetobacter infections.
引用
收藏
页码:1163 / 1167
页数:5
相关论文
共 50 条
  • [41] Overcoming addition of phosphoethanolamine to lipid A mediated colistin resistance in Acinetobacter baumannii clinical isolates with colistin–sulbactam combination therapy
    Sukrit Srisakul
    Dhammika Leshan Wannigama
    Paul G. Higgins
    Cameron Hurst
    Shuichi Abe
    Parichart Hongsing
    Thammakorn Saethang
    Sirirat Luk-in
    Tingting Liao
    Naris Kueakulpattana
    Aye Mya Sithu Shein
    Lin Gan
    Rosalyn Kupwiwat
    Chanikan Tanasatitchai
    Pattama Wapeesittipan
    Phatthranit Phattharapornjaroen
    Vishnu Nayak Badavath
    Asada Leelahavanichkul
    Tanittha Chatsuwan
    Scientific Reports, 12
  • [42] Colistin resistance mechanism in Acinetobacter nococomialis and Acinetobacter seiferti isolates
    Chung, E. S.
    Park, Y. K.
    Lee, J. -Y.
    Ko, K. S.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 45 : S79 - S79
  • [43] Variations of AbaR4-Type Resistance Islands in Acinetobacter baumannii Isolates from South Korea
    Kim, Dae Hun
    Park, Young Kyoung
    Ko, Kwan Soo
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (08) : 4544 - 4547
  • [44] Hetero- and adaptive resistance to polymyxin B in OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolates
    Juliana Barin
    Andreza Francisco Martins
    Bianca Lucia Heineck
    Afonso Luis Barth
    Alexandre Prehn Zavascki
    Annals of Clinical Microbiology and Antimicrobials, 12
  • [45] Hetero- and adaptive resistance to polymyxin B in OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolates
    Barin, Juliana
    Martins, Andreza Francisco
    Heineck, Bianca Lucia
    Barth, Afonso Luis
    Zavascki, Alexandre Prehn
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2013, 12
  • [46] Molecular characterization of lpxACD and pmrA/B two-component regulatory system in the colistin resistance Acinetobacter baumannii clinical isolates
    Ghahraman, Mohammad Reza Kandehkar
    Hosseini-Nave, Hossein
    Azizi, Omid
    Shakibaie, Mohammad Reza
    Mollaie, Hamid Reza
    Shakibaie, Samane
    GENE REPORTS, 2020, 21
  • [47] High-intensity meropenem combinations with polymyxin B: new strategies to overcome carbapenem resistance in Acinetobacter baumannii
    Lenhard, Justin R.
    Bulitta, Jurgen B.
    Connell, Terry D.
    King-Lyons, Natalie
    Landersdorfer, Cornelia B.
    Cheah, Soon-Ee
    Thamlikitkul, Visanu
    Shin, Beom Soo
    Rao, Gauri
    Holden, Patricia N.
    Walsh, Thomas J.
    Forrest, Alan
    Nation, Roger L.
    Li, Jian
    Tsuji, Brian T.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (01) : 153 - 165
  • [48] Investigation of biofilm formation in Acinetobacter baumannii isolates and their colistin susceptibilities in biofilm
    Sezgin, Fikriye Milletli
    Coban, Ahmet Yilmaz
    Gunaydin, Murat
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 41 (02) : 199 - 199
  • [49] Triclosan resistance in clinical isolates of Acinetobacter baumannii
    Chen, Yagang
    Pi, Borui
    Zhou, Hua
    Yu, Yunsong
    Li, Lanjuan
    JOURNAL OF MEDICAL MICROBIOLOGY, 2009, 58 (08) : 1086 - 1091
  • [50] Overcoming addition of phosphoethanolamine to lipid A mediated colistin resistance in Acinetobacter baumannii clinical isolates with colistin-sulbactam combination therapy
    Srisakul, Sukrit
    Wannigama, Dhammika Leshan
    Higgins, Paul G.
    Hurst, Cameron
    Abe, Shuichi
    Hongsing, Parichart
    Saethang, Thammakorn
    Luk-in, Sirirat
    Liao, Tingting
    Kueakulpattana, Naris
    Shein, Aye Mya Sithu
    Gan, Lin
    Kupwiwat, Rosalyn
    Tanasatitchai, Chanikan
    Wapeesittipan, Pattama
    Phattharapornjaroen, Phatthranit
    Badavath, Vishnu Nayak
    Leelahavanichkul, Asada
    Chatsuwan, Tanittha
    SCIENTIFIC REPORTS, 2022, 12 (01)